AM BIOTECHNOLOGIES, LLC — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for AM BIOTECHNOLOGIES, LLC, built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like AM BIOTECHNOLOGIES, LLC

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
1R43GM126604-01 Department of Health and Human Services $304,226 SBIR · Phase I 2018-06-01
2R44GM108110-03 Department of Health and Human Services $1,259,621 SBIR · Phase II 2015-09-01
W911NF-14-P-0038 Department of Defense $99,975 SBIR · Phase I 2014-09-24
NNX10CA98C National Aeronautics and Space Administration $600,000 SBIR · Phase II 2010-06-28
2R44GM084552-03 Department of Health and Human Services $949,235 SBIR · Phase II
N43DA201000013 Department of Health and Human Services $200,000 SBIR · Phase I
1R43GM086937-01A1 Department of Health and Human Services $156,729 SBIR · Phase I
1R43GM100777-01 Department of Health and Human Services $180,115 SBIR · Phase I
2R44GM086937-02 Department of Health and Human Services $996,569 SBIR · Phase II
1R43GM108110-01 Department of Health and Human Services $449,824 SBIR · Phase I

Frequently asked questions

How many SBIR/STTR awards has AM BIOTECHNOLOGIES, LLC won?

AM BIOTECHNOLOGIES, LLC has won 10 SBIR/STTR awards worth $5,196,294 in the public federal award records SBIR Signal tracks, including 6 Phase I and 4 Phase II award(s).

Which agencies fund AM BIOTECHNOLOGIES, LLC?

AM BIOTECHNOLOGIES, LLC's awards come from 3 agencies on record; its top funder is Department of Health and Human Services.

What technology areas does AM BIOTECHNOLOGIES, LLC work in?

Based on its award history, AM BIOTECHNOLOGIES, LLC works in a range of technology areas.

How do I find firms similar to AM BIOTECHNOLOGIES, LLC?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.